Dermata Therapeutics, Inc. Warrant (NASDAQ: DRMAW) last traded at $0.000600, down 50.00% on the session. The quote above updates while this page is open; the figures below are drawn from Dermata Therapeutics, Inc. Warrant’s own filings and are restated only when a new one is published.
Dermata Therapeutics, Inc. Warrant trades on NASDAQ under the ticker DRMAW. Its market capitalisation is $2,413.286.
Valuation measures for Dermata Therapeutics, Inc. Warrant, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.4K |
|---|---|
| Enterprise value | -$2.58M |
| Price / book | 0.00 |
Trailing-twelve-month figures tagged in Dermata Therapeutics, Inc. Warrant's XBRL filings with the SEC.
| Net income (TTM) | -$8.37M |
|---|---|
| Return on equity |
|---|
| -239.95% |
| Cash | $4.41M |
|---|
Range and volume for DRMAW over the past 52 weeks.
| 52-week high | $0.00110 |
|---|---|
| 52-week low | $0.000500 |
| Volume | 146.1K |
| Average volume | 146.1K |
| Previous close | $0.00120 |
Invest a chosen dollar amount in Dermata Therapeutics, Inc. Warrant with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DRMAW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.